Treatment of acute myeloid leukemia cells in vitro with a monoclonal antibody recognizing a myeloid differentiation antigen allows normal progenitor cells to be expressed.

Monoclonal antibody L4F3 reacts with most acute myeloid leukemia (AML) cells and virtually all normal granulocyte/monocyte colony-forming cells (CFU-GM). Our objective was to determine whether lysis of AML cells with L4F3 and complement allowed expression of normal myeloid progenitors. The five gluc...

Descripción completa

Detalles Bibliográficos

Publicado en:	J Clin Invest
Autores principales:	Bernstein, I D, Singer, J W, Andrews, R G, Keating, A, Powell, J S, Bjornson, B H, Cuttner, J, Najfeld, V, Reaman, G, Raskind, W
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	American Society for Clinical Investigation 1987
Materias:	Research Article
Acceso en línea:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC424297/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3470307/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI112932
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!